Weight Loss Treatment
Fast review, often within 2 hours
If weight loss has felt harder than it should, you’re not alone.
- Personalised plan, reviewed by clinicians
- Treatments from $99, no long-term commitment
- Ongoing support at every step of treatment
Weight loss injections
Extra support when willpower alone isn’t enough. Prescription injections assessed by our clinicians to help regulate appetite and support steady progress.
Wegovy
Buy once-weekly Wegovy GLP-1 injection pens that help reduce appetite and support sustainable weight loss.
- Up to 20% body weight loss in studies
- Once-weekly injection
- Well-established safety profile
From $75
with Subscribe & Save
Mounjaro
Mounjaro is a once-weekly injection pen that targets two hormones (GLP-1 and GIP) for enhanced weight loss results.
- Up to 22.5% body weight loss in studies
- Once-weekly injection
- Dual hormone action (GLP-1 + GIP)
From $129
with Subscribe & Save
Weight loss pills
Support in a form that fits your routine. Oral prescription treatments assessed by our clinical team and used alongside diet and activity changes.
Wegovy pill
Daily oral semaglutide for weight loss, assessed through our clinician-led service.
From $99
with Subscribe & Save
Foundayo
Once-daily oral pills for weight loss, assessed through our clinician-led service.
From $64.09
with Subscribe & Save
Orlistat
Generic orlistat for adults with a BMI of 28+ that reduces fat absorption when taken with meals.
From $11.95
More ways to pay
Subscribe & Save, or pay as you go
Weight loss isn’t one size fits all, and now, neither is how you pay. Choose Pay As You Go for full month-to-month flexibility, or Subscribe & Save for automatic re-ordering, 10% off every subscription order and less admin each month.
Mounjaro vs Wegovy at a glance
Both are once-weekly injections prescribed for weight loss. They're effective in different ways, and the right choice depends on how your body responds, not just the headline numbers.
| Quick comparison | Mounjaro | Wegovy |
|---|---|---|
| How it works | Dual GIP and GLP-1 receptor agonist | GLP-1 receptor agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Average weight change at 72 weeks* | 20.2% reduction | 13.7% reduction |
| Dosing | Once-weekly injection | Once-weekly injection |
| Common side effects | Mainly gastrointestinal | Mainly gastrointestinal |
*SURMOUNT-5 directly compared maximum tolerated doses of tirzepatide and semaglutide alongside lifestyle support in adults with obesity but without type 2 diabetes. Individual results vary.
How to get started
Taking the first steps to feeling healthier overall.
Complete a simple assessment
Answer questions about your health, lifestyle, and goals.
Your assessment is reviewed by a clinician
A Canadian-licensed prescriber carefully reviews your assessment to ensure treatment is safe and suitable for you.
Receive discreet delivery
Your medication is dispensed by our registered pharmacy and delivered to your door in plain packaging.
Stay supported
Schedule reviews with our specialist teams to monitor progress and support you throughout your journey.
47,000+ verified customer reviews
Real stories from our patients
I've had some great conversations with the pharmacists at Miva. I've really felt listened to, and that I'm not just an internet order that gets ticked off.
The assessment was straightforward and my treatment arrived two days later. The dosing support has made all the difference.
Fast approval, clear guidance and a team that actually replies. Six months in and I'm still supported.
Weight loss questions we hear often
Join the Miva list
Sign up now
Leave your email and we’ll let you know the moment consultations open, plus early access to Miva treatment pricing.
No spam. Unsubscribe at any time. We never share your details.
Ready to take the first step?
Complete your assessment today and a Canadian-licensed clinician will review it, often within 2 hours.